Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane PRO vs Blink Triple Care in Dry Eye Disease
NCT07745062Phase 4Recruiting
- Sponsor
- Gordon Schanzlin New Vision Institute
- Start
- Jul 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 4 trial of Systane PRO in dry eye disease (DED), sponsored by Gordon Schanzlin New Vision Institute. Started Jul 2026; status: recruiting.
02
Drugs
Systane PRO
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07745062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07745062.